US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 7.760
  • +0.030+0.39%
Close Feb 14 16:00 ET
151.57MMarket Cap-5.33P/E (TTM)

Actuate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Actuate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--

Actuate Therapeutics Earnings Reports

  • Actuate Therapeutics | 10-Q: Quarterly report

    Nov 13, 2024 16:02 ET

  • Actuate Therapeutics | 10-Q: Quarterly report

    Sep 24, 2024 16:07 ET

    • Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    XINGANJIANG
    873167
    +30.00%
    INNOVATIVE DATA
    835305
    +29.98%
    CHENGUANG MEDICAL
    430300
    +29.96%
    4
    Hangzhou Gaoxin Materials Technology
    300478
    +20.04%
    5
    Beijing Philisense Technology
    300287
    +20.03%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Earnings Season Underway
    Earnings season is here. What to know?
    Discussing
    Tesla's earnings caused fluctuations, what's your market outlook？
    Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
    TSLA earnings preview: Grab rewards by guessing the opening price!